Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
39.38
+1.27 (3.33%)
At close: Dec 5, 2025, 4:00 PM EST
39.98
+0.60 (1.52%)
After-hours: Dec 5, 2025, 6:51 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $2.11 billion as of December 5, 2025. Its market cap has increased by 248.84% in one year.
Market Cap
2.11B
Enterprise Value
1.82B
1-Year Change
248.84%
Ranking
Category
Stock Price
$39.38
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $2.11B, an increase of 212.49%. That is a compound annual growth rate of 153.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.11B | 517.61% |
| Dec 31, 2024 | 342.27M | -49.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 905.41B |
| Johnson & Johnson | 486.87B |
| AbbVie | 398.77B |
| UnitedHealth Group | 299.34B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.73B |
| Merck & Co. | 247.26B |
| Abbott Laboratories | 218.23B |